Prasugrel

Type: Product
Name: Prasugrel
First reported Aug 25 2014 - Updated Aug 26 2014 - 3 reports

NPPA grants price exemption for Torrent Pharma's FDC drug

Torrent Pharma has apparently become the first company to receive price exemption for a new drug from National Pharmaceutical Pricing Authority (NPPA) under the new drug pricing policy, which came into effect last year, according to a Business Standard. ... [Published Business Standard India - Aug 26 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

TEVA PHARMACEUTICAL : Patent Issued for Crystalline Forms of Prasugrel Salts

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Alexandria, Virginia , by NewsRx journalists, a patent by the inventors Tuksar, Mihaela (Cakovec, HR); Biljan, Tomislav (Krizevci, HR); Zegarac, ... [Published 4 Traders - Aug 21 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

AHA announces late-breaking clinical trials for annual Scientific Sessions

The American Heart Association has announced the line-up of late-breaking clinical trials slated for presentation at its annual Scientific Sessions in Chicago.According to a press release, the meeting will feature four late-breaking clinical trial sessions ... [Published Orthopedics Today - Aug 13 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

EFFIENT (Prasugrel Hydrochloride) Tablet, Film Coated [Eli Lilly And Company ]

First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Crystalline forms of Prasugrel salts

Salts of prasugrel were prepared including, for example, crystalline forms of prasugrel hydrobromide. These salts are useful, for example, in medicaments that inhibit the aggregation of platelets. ... [Published Free Patents Online - Aug 12 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Effects of Solvent on Polymorph Formation and Nucleation of Prasugrel Hydrochloride

Three intrinsic properties of solvent were used to evaluate the effects of solvent on polymorph formation of prasugrel hydrochloride. In situ Raman spectroscopy, FTIR, and powder X-ray diffraction were used to characterize two solvent-free polymorphs ... [Published Crystal Growth & Design - Aug 06 2014]
First reported Aug 04 2014 - Updated Aug 04 2014 - 1 reports

Double Ticagrelor Loading Dose vs Standard in STEMI

The Rapid Activity of Platelet Inhibitor Drugs (RAPID) Primary PCI 2 StudyGuido Parodi, MD, Benedetta Bellandi, MD, Renato Valenti, MD, Angela Migliorini, MD, Rossella Marcucci, MD, Nazario Carrabba, MD, Letizia Giurlani, MD, Gian Franco Gensini, ... [Published Theheart.org - Aug 04 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

Late-breaking trials, first report investigations announced for TCT

The Cardiovascular Research Foundation has announced the lineup for the late-breaking trials and first report investigations for this year’s Transcathether Cardiovascular Therapeutics Scientific Symposium.The meeting, which will take place from Sept. ... [Published Orthopedics Today - Aug 01 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

Triumphs and Regrets of an Early Adopter

Editor's Note: On July 1, Dr. Bilazarian's practice was acquired and he became an employed physician. To reflect this change, his series will be renamed Practitioner's Corner.To download the slides used in Dr. Bilazarian's presentation, click here .Seth ... [Published General Medicine eJournal - Jul 31 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

Can warfarin improve psychotic symptoms

Anna Garrett An interesting preliminary study suggests that warfarin use may lead to a decrease in and even long-term remission of psychotic symptoms in patients with schizophrenia.A study of adults with deep vein thrombosis (DVT) showed that five patients ... [Published Drugtopics.com - Jul 31 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 3 reports

Heart patients in England and Wales offered more choice of therapies as NICE extends recommendations for prasugrel

Related Biotechnology, Pharmaceutical and Healthcare NewsRevised guidance from the National Institute for Health and Care Excellence, recommends once-daily, oral antiplatelet prasugrel (Efient®)...Original Article: NEXT ARTICLE More From BioPortfolio ... [Published BioPortfolio - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 4 reports

UK's NICE changes guidance to recommend Eli Lilly’s Efient for blood clots

The National Institute for Health and Care Excellence (NICE), the UK’s health care guidance body, has reviewed and updated its guidance on Efient (prasugrel), produced by US drug major Eli Lilly (NYSE: LLY).The new guidance recommends the drug in combination ... [Published Pharma Letter - Jul 23 2014]

Quotes

"In another embodiment, the present invention encompasses a pharmaceutical composition comprising any of the above described salts and crystalline forms and at least one pharmaceutically acceptable excipient."
According to the news editors, the research concluded: "In the basic series, 20c (BMS-884775) was discovered with an improved PK and liability profile over 1. These results support P2Y(1) antagonism as a promising new antiplatelet target."
The complaints in these cases are substantially identical.  Infringement of U S Patent Nos. 5,540,938 ( "Formulations and Their Use in the Treatment of Neurological Diseases" issued July 30, 1996), 8,007,826 ("Sustained Release Aminopyridine Composition," issued August 30, 2011), 8,354,437 ("Method of Using Sustained Release...

More Content

All (43) | News (35) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
NPPA grants price exemption for Torrent Pharma'... [Published Business Standard India - Aug 26 2014]
Torrent Pharma gets price exemption for new FDC... [Published FirstWord Pharma - Aug 25 2014]
Torrent Pharma gets price exemption for new FDC... [Published Business Standard India - Aug 25 2014]
TEVA PHARMACEUTICAL : Patent Issued for Crystal... [Published 4 Traders - Aug 21 2014]
BRISTOL MYERS SQUIBB : Studies from Bristol-Mye... [Published 4 Traders - Aug 20 2014]
TEVA PHARMACEUTICAL : Assigned Patent [Published 4 Traders - Aug 14 2014]
AHA announces late-breaking clinical trials for... [Published Orthopedics Today - Aug 13 2014]
EFFIENT (Prasugrel Hydrochloride) Tablet, Film ... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Crystalline forms of Prasugrel salts [Published Free Patents Online - Aug 12 2014]
Effects of Solvent on Polymorph Formation and N... [Published Crystal Growth & Design - Aug 06 2014]
Court Report - August 2014 [Published JD Supra - Aug 05 2014]
Double Ticagrelor Loading Dose vs Standard in S... [Published Theheart.org - Aug 04 2014]
TCT.14: Late-breakers cover TAVR, scaffolds & more [Published Cardiovascular Business - Aug 02 2014]
Late-breaking trials, first report investigatio... [Published Orthopedics Today - Aug 01 2014]
CRF announces late-breaking trials and first re... [Published EurekAlert! - Aug 01 2014]
AstraZeneca Group's (AZN) CEO Pascal Soriot on ... [Published Seeking Alpha - Aug 01 2014]
Triumphs and Regrets of an Early Adopter [Published General Medicine eJournal - Jul 31 2014]
Can warfarin improve psychotic symptoms [Published Drugtopics.com - Jul 31 2014]
Court Report -- Part II - July 2014 #2 [Published JD Supra - Jul 30 2014]
PCI and ACS: Where Do Vorapaxar and Bivalirudin... [Published Theheart.org - Jul 30 2014]
ACS Antithrombotics: Back to the Future? [Published General Medicine eJournal - Jul 29 2014]
Heart patients in England and Wales offered mor... [Published BioPortfolio - Jul 24 2014]
NICE extends recommendation for Efient [Published Pharmafocus - Jul 24 2014]
Heart patients in England and Wales offered mor... [Published Medical News Today - Jul 24 2014]
Lilly's Efient receives new NICE recommendation [Published Zenopa - Jul 24 2014]
NICE recommends drugs for blood clots and const... [Published BioPortfolio - Jul 24 2014]
Lilly’s Efient and Sucampo's Amitiza win NICE b... [Published PMLive - Jul 23 2014]
UK's NICE changes guidance to recommend Eli Lil... [Published Pharma Letter - Jul 23 2014]
Daiichi Sankyo and Eli Lilly and Company: Heart... [Published Business Wire Health News - Jul 23 2014]
Cost watchdog expands NHS use of bloodthinner E... [Published Pharma Times - Jul 23 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
EFFIENT (Prasugrel Hydrochloride) Tablet, Film ... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Updated Date: Aug 12, 2014 EST ...
Daiichi Sankyo and Eli Lilly and Company: Heart... [Published Business Wire Health News - Jul 23 2014]
GERRARDS CROSS, England--(BUSINESS WIRE)--Revised guidance from the National Institute for Health and Care Excellence (NICE), recommends once-daily, oral antiplatelet prasugrel (Efient®), in combination with aspirin, as a cost-effective option when compared ...
Court Report [Published Patent Docs - Jul 07 2014]
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Eli Lilly and Company et al. v. Panacea Biotec, Ltd. 1:14-cv-01064; filed June 26, 2014 in the Southern District of Indiana•Plaintiffs: ...
Court Report - Part III [Published Patent Docs - Apr 25 2014]
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Eli Lilly and Company et al. v. Apotex Corp. et al. 1:14-cv-00586; filed April 16, 2014 in the Southern District of Indiana•Plaintiffs: ...
Top medicine articles for April 2014 [Published Clinical Cases and Images: CasesBlog - Apr 17 2014]
A collection of some interesting medical articles published recently:Noninfluenza Vaccination Rates Among U.S. Adults Remain Low - only 16% for Tdap in 2012 http://buff.ly/NcduqD Adult Tonsillectomy Shown to Be Safe: 30-day mortality rate was low, ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.